drugset
Drugs / Kenalog-40
last change Dec 2025 re-read 3 minutes ago

Kenalog-40

Other / unclassified

Developed for
rotator cuff syndrome

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) KENALOG-40 — 1965-02-01 fda.gov ↗

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT06712290 Comparator Nov 2024 → Dec 2025 rotator cuff syndrome Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Kenalog-40 “Kenalog-40 is a long-acting corticosteroid injection for intramuscular (into the muscle) or intra-articular (into the joints) use.” NCT06712290 ↗
Modality Other / unclassified “Kenalog-40 is a long-acting corticosteroid injection” NCT06712290 ↗
Route Other “a 2.0cc dose injection of Kenalog-40 will be administered directly into the subacromial space using a 20G needle” NCT06712290 ↗